This study also highlights the therapeutic potential of targeting TOP2B using ASO for preventing AIC in patients with cancer, offering new insights into cardioprotective strategies.<h4>Significance</h4>Anthracycline chemotherapy can cause severe and sometimes fatal heart damage, limiting its clinical use. Here, TOP2B is linked to cancer.